1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Test Type
• Market Snippet, By Cancer Type
• Market Snippet, By End User
• Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Recent Test Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Lung Cancer Diagnostic and Screening Market, By Test Type, 2021–2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022–2033
• Segment Trends
• Biomarkers Test
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
• Segment Trends
• EGFR Mutation Test
• KRAS Mutation Test
• ALK Test
• HER2 Test
• Others
• Imaging Test
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
• Segment Trends
• Computed Tomography (CT) scan
• Positron Emission Tomography (PET) scan
• Chest X-Ray
• Others
• Biopsy
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
• Segment Trends

5. Global Lung Cancer Diagnostic and Screening Market, By Cancer Type, 2021–2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022–2033
• Segment Trends
• Non-small cell lung cancer
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
• Segment Trends
• Small Cell Lung Cancer
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
• Segment Trends

6. Global Lung Cancer Diagnostic and Screening Market, By End User, 2021–2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022–2033
• Segment Trends
• Hospital Associated Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
• Independent Diagnostic Laboratories
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
• Cancer Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)

7. Global Lung Cancer Diagnostic and Screening Market, By Region, 2021–2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022–2033
• Segment Trends
• North America
• Introduction
• Market Size and Forecast, Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast, Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
• Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
• U.S.
• Canada
• Europe
• Introduction
• Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
• Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
• Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Introduction
• Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
• Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
• Introduction
• Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
• Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
• Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
• Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Company Profiles
• Abbott
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Amgen Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Illumina, Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Thermo Fisher Scientific Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Lepu Medical Technology(Beijing)Co.,Ltd.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• AstraZeneca
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• F. Hoffmann-La Roche Ltd
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Laboratory Corporation of America Holdings.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Agilent Technologies, Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• QIAGEN
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Quest Diagnostics Incorporated.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• NeoGenomics Laboratories.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Myriad Genetics, Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• GRAIL, LLC.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• DELFI Diagnostics
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact